Generation of in vitro autologous human cytotoxic T-cell response to E7 and HER-2/neu oncogene products using ex-vivo peptide loaded dendritic cells.
Navabi
H
H
Department of Clinical Oncology, Velindre NHS Trust Whitchurch, Cardiff.
Jasani
B
B
Adams
M
M
Evans
A S
AS
Mason
M
M
Crosby
T
T
Borysiewicz
L
L
D000595:Amino Acid Sequence; D017951:Antigen Presentation; D001324:Autoantigens; D003713:Dendritic Cells / Q000276:immunology*; D005260:Female; D005833:Genital Neoplasms, Female / Q000276:immunology / Q000628:therapy; D015395:Histocompatibility Antigens Class I / Q000378:metabolism; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D066298:In Vitro Techniques; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000276:immunology*; D027383:Papillomaviridae / Q000276:immunology; D050725:Papillomavirus E7 Proteins; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D001324:Autoantigens; D015395:Histocompatibility Antigens Class I; D009856:Oncogene Proteins, Viral; D050725:Papillomavirus E7 Proteins; D010446:Peptide Fragments; D018719:Erb-b2 Receptor Tyrosine Kinases; C059731:oncogene protein E7, Human papillomavirus type 16